Suppr超能文献

导致注意缺陷多动障碍儿童和青少年停药和重新开始服药的原因。

Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.

机构信息

Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

出版信息

Acad Pediatr. 2018 Apr;18(3):273-280. doi: 10.1016/j.acap.2017.09.005. Epub 2017 Sep 12.

Abstract

OBJECTIVE

To describe the prevalence of reasons why children and adolescents stop and restart attention-deficit/hyperactivity disorder (ADHD) medicine and whether functional impairment is present after stopping medicine.

METHODS

We used the prospective longitudinal cohort from the Multimodal Treatment of Study of Children With ADHD. At the 12-year follow-up, when participants were a mean of 21.1 years old, 372 participants (76% male, 64% white) reported ever taking ADHD medicine. Participants reported the age when they last stopped and/or restarted ADHD medicine and also endorsed reasons for stopping and restarting.

RESULTS

Seventy-seven percent (286 of 372) reported stopping medicine for a month or longer at some time during childhood or adolescence. Participants were a mean of 13.3 years old when they last stopped medicine. The most commonly endorsed reasons for stopping medication related to 1) medicine not needed/helping, 2) adverse effects, 3) logistical barriers of getting or taking medication, and 4) social concerns or stigma. Seventeen percent (64 of 372) reported restarting medicine after stopping for a month or longer. Commonly endorsed reasons for restarting related to medicine being needed or medicine helping; and resolution of logistical barriers to getting or taking medicine. For both stopping and restarting, the proportion endorsing some reasons differed by age range, with the overall pattern suggesting that parental involvement in decisions decreased with age. Nearly all participants had impairment at the assessment after stopping, regardless of whether medication was resumed.

CONCLUSIONS

Different reasons for stopping and/or restarting medicine are relevant at different times for different teens. Tailored strategies may help engage adolescents as full partners in their treatment plan.

摘要

目的

描述儿童和青少年停止和重新开始使用注意力缺陷/多动障碍(ADHD)药物的原因,并探讨停药后是否存在功能障碍。

方法

我们使用了 ADHD 多模式治疗研究的前瞻性纵向队列。在 12 年的随访中,当参与者的平均年龄为 21.1 岁时,372 名参与者(76%为男性,64%为白人)报告曾服用过 ADHD 药物。参与者报告了他们最后一次停止和/或重新开始 ADHD 药物的年龄,并列举了停止和重新开始的原因。

结果

77%(372 名中的 286 名)报告在儿童或青少年时期的某个时候曾停止服用药物一个月或更长时间。参与者最后一次停止用药的平均年龄为 13.3 岁。停止用药最常见的原因与以下四个方面有关:1)药物不需要/帮助不大,2)不良反应,3)获取或服用药物的实际困难,4)社会关注或耻辱感。17%(372 名中的 64 名)报告在停止用药一个月或更长时间后重新开始用药。重新开始用药的常见原因与药物的必要性或药物的帮助有关,同时也与解决获取或服用药物的实际困难有关。对于停止和重新开始用药,不同年龄段的参与者对某些原因的认同程度存在差异,总体模式表明,父母对决策的参与随着年龄的增长而减少。几乎所有参与者在停药后评估时都存在功能障碍,无论是否重新开始服用药物。

结论

不同的停药和/或重新开始用药的原因在不同的时间对不同的青少年具有相关性。针对特定情况的个体化策略可能有助于让青少年作为其治疗计划的完全参与者。

相似文献

1
Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.
Acad Pediatr. 2018 Apr;18(3):273-280. doi: 10.1016/j.acap.2017.09.005. Epub 2017 Sep 12.
4
Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Pediatrics. 2009 Aug;124(2):580-9. doi: 10.1542/peds.2008-2569. Epub 2009 Jul 27.
7
Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol. 2012 Jun;22(3):226-37. doi: 10.1089/cap.2011.0090. Epub 2012 Apr 26.
8
Predictors of Medication Continuity in Children With ADHD.
Pediatrics. 2018 Jun;141(6). doi: 10.1542/peds.2017-2580.
9
Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol. 2014 Oct;24(8):442-7. doi: 10.1089/cap.2014.0002. Epub 2014 Jul 10.
10
Patterns of long-term ADHD medication use in Australian children.
Arch Dis Child. 2020 Jun;105(6):593-597. doi: 10.1136/archdischild-2019-317997. Epub 2020 Jan 14.

引用本文的文献

1
Reduced Efficacy of Behavior Therapy Following Initial Multimodal Treatment of ADHD.
Evid Based Pract Child Adolesc Ment Health. 2025;10(2):485-501. doi: 10.1080/23794925.2024.2384092. Epub 2024 Aug 13.
5
Trait mindfulness in adolescents with and without Attention-Deficit/Hyperactivity Disorder.
Res Dev Disabil. 2025 Mar;158:104926. doi: 10.1016/j.ridd.2025.104926. Epub 2025 Jan 31.
6
Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD.
Npj Ment Health Res. 2024 Jun 19;3(1):30. doi: 10.1038/s44184-024-00075-w.
7
Attention-deficit/hyperactivity disorder.
Nat Rev Dis Primers. 2024 Feb 22;10(1):11. doi: 10.1038/s41572-024-00495-0.

本文引用的文献

2
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453.
3
Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.
J Am Acad Child Adolesc Psychiatry. 2016 Apr;55(4):289-94. doi: 10.1016/j.jaac.2016.02.001. Epub 2016 Feb 5.
5
The necessity-concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis.
Patient Educ Couns. 2016 May;99(5):706-17. doi: 10.1016/j.pec.2015.11.004. Epub 2015 Nov 14.
7
Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents.
BMC Psychiatry. 2014 Apr 12;14:110. doi: 10.1186/1471-244X-14-110.
8
Relationship of youth involvement in diabetes-related decisions to treatment adherence.
J Clin Psychol Med Settings. 2014 Jun;21(2):183-9. doi: 10.1007/s10880-014-9388-1.
9
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2. doi: 10.1016/j.jaac.2013.09.001. Epub 2013 Nov 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验